Clinical Trial Detail

NCT ID NCT02641002
Title A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene
Indications

myelodysplastic syndrome

acute myeloid leukemia

Therapies

CC-90002

Age Groups: adult senior

No variant requirements are available.